What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

ProRx Pharma Continues to Expand Preventative Health Portfolio with Six New Products

ProRx Pharma Continues to Expand Preventative Health Portfolio with Six New Products

ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the addition of six new injectable products designed to support the rising demand for preventive care: Gonadorelin, Liraglutide, Vitamin D3, and Phenylephrine HCl as well as two Tri-Mix injection options.

These high-quality standalone injectables are now available for bulk shipping to licensed medical facilities in 26 states and for direct-to-consumer shipping nationwide through ProRx’s growing network of 503A pharmacies, clinics, med spas and telehealth providers. Read More >

ProRx Pharma

ProRx Pharma News & Announcements

ProRx Pharma is an FDA-registered 503B facility focused on providing essential compounded sterile and non-sterile preparations. The company compounds products and formulations for medical institutions, physician offices, and 503A pharmacies, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from ProRx Pharma Continues to Expand Preventative Health Portfolio with Six New Products

Name
Address
Subscribe